None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Able and willing to provide written informed consent. 2.Available for entire 6 8-week study duration. 3. Fitzpatrick skin type determined (I VI) with intentional inclusion of darker skin types (V VI) per NEA guidance. 4. Healthy intact skin on test sites (upper back/volar forearm) without sunburn, wounds, or active dermatitis. 5. For sensitive/eczema-prone group: self-reported history of eczema or sensitive skin but stable condition. 6. Willing to refrain from new topical or systemic skin treatments during study. 7. Agree to avoid sun exposure, swimming, and vigorous exercise during patching periods.
Exclusion criteria
Exclusion criteria: 1.Active flare of eczema/atopic dermatitis, psoriasis, acne,or infection on the test site. 2. Known hypersensitivity to adhesives, occlusive patches,or any study product ingredients. 3. Systemic corticosteroid, immunosuppressive, or antihistamine therapy within 14 days. 4. Topical corticosteroid or retinoid use on test site within 7 days. 5. History of keloid scarring or poor wound healing. 6. Pregnancy or lactation. 7. Participation in another investigational study within 30 days. 8. Any condition judged by investigator to interfere with the test or safety evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To determine the irritation and/or sensitization potential of a test material 2.In support of sensitive skin claims and supporting evidence for hypoallergenicity claims after repeated application under occlusive or semi-occlusive patches to the skin of human subjects.Timepoint: Day 1 to Day 40 | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence & rate of adverse events.Timepoint: Day 1 to Day 40 | — |
Countries
India
Contacts
Radiant Research Services Pvt Ltd